A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017

Clinical trial NCT06980207 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06980207
Sponsor: Luye Pharma Group Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis Hallucinations and Delusions Associated With Parkinson Disease Psychosis Negative Symptoms of Schizophrenia

Start date: 2025-05-01
Primary completion: 2025-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.